TBC1D16 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-57666
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Summary for TBC1D16 Antibody
Immunogen
Synthetic peptides corresponding to TBC1D16 (TBC1 domain family, member 16) The peptide sequence was selected from the N terminal of TBC1D16)(50ug).
Peptide sequence EMLGATLILAWVPNSRIQRQDEEALRYITPESSPVRKAPRPRGRRTRSSG. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for TBC1D16 Antibody
Western Blot: TBC1D16 Antibody [NBP1-57666]
Western Blot: TBC1D16 Antibody [NBP1-57666] - HT1080 cell lysate, concentration 0.2-1 ug/ml.Applications for TBC1D16 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TBC1D16
Alternate Names
FLJ20748, MGC25062, TBC1 domain family member 16, TBC1 domain family, member 16
Gene Symbol
TBC1D16
UniProt
Additional TBC1D16 Products
Product Documents for TBC1D16 Antibody
Product Specific Notices for TBC1D16 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...